Cancer stem cells: A step toward the cure

Journal of Clinical Oncology

Volumn 26, Issue 17, 2008, Pages 2795-2799

  Boman, Bruce M ^a   Wicha, Max S ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER; ANTINEOPLASTIC AGENT; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL FUNCTION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CYTOLOGY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; MATHEMATICAL MODEL; METASTASIS; MOLECULAR DYNAMICS; ONCOLOGY; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; ANIMAL; BIOLOGICAL MODEL; CANCER INVASION; CELL SEPARATION; CELL TRANSFORMATION; DRUG EFFECT; EDITORIAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MUTATION; NEOPLASM; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 45549096766     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.17.7436     Document Type: Review

References (52)

1. Wicha MS, Liu S, Dontu G: Cancer stem cells: An old idea - A paradigm shift. Cancer Res 66:1883-1890, 2006
2. Mackillop WJ, Ciampi A, Till JE, et al: A stem cell model of human tumor growth: Implications for tumor cell clonogenic assays. J Natl Cancer Inst 70:9-16, 1983
3. Julius Cohnheim: (1839-1884) experimental pathologist. JAMA 206:1561-1562, 1968
4. Lapidot T, Sirard C, Vormoor J, et al: A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 367:645-648, 1994
5. Ailles LE, Gerhard B, Kawagoe H, et al: Blood 94:1761-1772, 1999
6. Fialkow PJ, Singer JW: Chronic leukemias, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles & Practice of Oncology. Philadelphia, PA, JB Lippincott, 1989, pp 1836-1852
7. Greaves MH, Mariri G, Newman RA, et al: Selective expression of the common acute lymphoblastic Leukemia gp100 antigen on immature lymphoid cells and their malignant counterparts. Blood 61:628-639, 1983
8. Minden MD: Stem cells in acute leukemia, in Golde DW, Takaku F (eds): Hemopoietic Stem Cells. New York, NY, Marcel Dekker, 1985, pp 274-289
9. Stevens LC: Origin of testicular teratomas from primordial germ cells. J Natl Cancer Inst 38:549-552, 1967
10. Pierce GB, Stevens LC, Nakane PK: Ultrastructural analysis of the early development of teratocarcinomas. J Natl Cancer Inst 39:755-773, 1967
11. Pierce GB, Damjanov I: The pathology of cancer, in McKinnel RG, Parchment RE, Damjanov I, et al (eds): The Biologic Basis of Cancer. New York, NY, Cambridge University Press, 2006, pp 14-50
12. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197:461-463, 1977
13. Selby P, Buick RN, Tannock I: A critical appraisal of the "human tumor stem-cell assay." N Engl J Med 308:129-134, 1983
14. Kummermehr J, Trott K-R: Tumor stem cells, in Potten CS (ed): Stem Cells. London, United Kingdom, Academic Press, 1997, pp 363-400
15. Potten CS, Hendry JH: Stem cells in murine small intestine, in Potten CS (ed): Stem Cells: Their Identification and Characterization. Edinburgh, United Kingdom, Churchill-Livingstone, 1983, pp 155-199
16. Molofsky AV, Pardal R, Morrison SJ: Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16:700-707, 2004
17. Boman BM, Wicha M, Fields JZ, et al: Symmetric division of cancer stem cells: A key mechanism in tumor growth that should be targeted in future therapeutic approaches. Clin Pharmacol Ther 81:893-898, 2007
18. Boman BM, Fields JZ, Cavanaugh KL, et al: How dysregulated colonic crypt dynamics cause stem cell overpopulation and initiate colon cancer. Cancer Res 68:3304-3313, 2008
19. Pierce GB, Nakane PK, Martinez-Hernandez A, et al: Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts. J Natl Cancer Inst 58:1329-1345, 1977
20. Brabletz T, Jung A, Spaderna S, et al: Migrating cancer stem cells: An integrated concept of malignant tumour progression. Nat Rev Cancer 5:744-749, 2005
21. Reya T, Morrison SJ, Clarke MF, et al: Stem cells, cancer, and cancer stem cells. Nature 414:105-111, 2001
22. Sell S, Leffert HL: Liver cancer stem cells. J Clin Oncol 26:2800-2805, 2008
23. Lee CJ, Dosch J, Simeone DM: Pancreatic cancer stem cells. J Clin Oncol 26:2806-2812, 2008
24. Nicolis SK: Cancer stem cells and "stemness" genes in neuro-oncology. Neurobiol Dis 25:217-229, 2007
25. Kakarala M, Wicha MS: Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol 26:2813-2820, 2008
26. Dirks PB: Brain tumor stem cells: Bringing order to the chaos of brain cancer. J Clin Oncol 26:2916-2924, 2008
27. Boman BM, Walters R, Fields JZ, et al: Colonic crypt changes during adenoma development in familial adenomatous polyposis: Immunohistochemical evidence for expansion of the crypt base cell population. Am J Pathol 165:1489-1498, 2004
28. Boman BM, Fields JZ, Bonham-Carter O, et al: Computer modeling implicates stem cell overproduction in colon cancer initiation. Cancer Res 61:8408-8411, 2001
29. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828, 2003
30. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432:396-401, 2004
31. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983-3988, 2003
32. O'Brien CA, Pollett A, Gallinger S, et al: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110, 2007
33. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445:111-115, 2007
34. Ginestier C, Hur M, Charafe-Jauffret E, et al: ALDH1 is a marker of normal and malignant breast stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567, 2007
35. Dalerba P, Dylla SJ, Park IK, et al: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104:10158-10163, 2007
36. Boman BM, Huang E: Human colon cancer stem cells: A new paradigm in gastrointestinal oncology. J Clin Oncol 26:2828-2838, 2008
37. Balic M, Lin H, Young L, et al: Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12:5615-5621, 2006
38. Pardal R, Clarke MF, Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3:895-902, 2003
39. Eyler CE, Rich JN: Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 26:2839-2845, 2008
40. Fan X, Eberhart CG: Medulloblastoma stem cells. J Clin Oncol 26:2821-2827, 2008
41. Jin L, Hope KJ, Zhai Q, et al: Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12:1167-1174, 2006
42. Glinsky GV, Olga Berezovska O, Glinskii AB: Microarray analysis identifies a death from cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115:1503-1521, 2005
43. Alexe G, Alexe S, Axelrod DE, et al: Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res 8:R41, 2006
44. van't Veer LJ, Dai H, van de Vijver, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002
45. Glinsky GV: "Stemness" genomics law governs clinical behavior of human cancer: Implications for decision making in disease management. J Clin Oncol 26:2846-2853, 2008
46. Dingli D, Michor F: Successful therapy must eradicate cancer stem cells. Stem Cells 24:2603-2610, 2006
47. Kern S, Shibata D: The fuzzy math of solid tumor stem cells: A perspective? Cancer Res 67:9885-9888, 2007
48. Roeder I, Horn M, Glauche I, et al: Dynamics modeling of imatinib-treated chronic myeloid leukemia: Funcational insights and clinical implications. Nat Med 12:1181-1184, 2006
49. Iwasa Y, Nowak MA, Michor F: Evolution of resistance during clonal expansion. Genetics 172:2557-2566, 2006
50. Komarova NL, Wodarz D: Effect of cellular quiescence on the success of targeted CML therapy. PLOS One 10:e990, 2007
51. Iwasa Y, Nowak MA, Michor F: Evolution of resistance during clonal expansion. Genetics 172:2257-2566, 2006
52. Michor F: Mathematical models of cancer stem cells. J Clin Oncol 26:2854-2861, 2008